TrinhNguyen (Talk | contribs) |
|||
Line 38: | Line 38: | ||
</li> | </li> | ||
</ul> | </ul> | ||
+ | |||
+ | <br><br> | ||
+ | |||
+ | <a href="https://2016.igem.org/Team:MIT"><h1 style="color:#ffffff; background-color:#F20253;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Back to Home</h1> </a> | ||
+ | |||
+ | <br><br> | ||
+ | <br><br><br> | ||
+ | <br> | ||
</html> | </html> |
Latest revision as of 23:50, 19 October 2016
Experiments
To tackle the size of this project, we organized our team into three sub-groups,
each addressing a synthetic biological tool that could assist in the diagnosing of
endometriosis. Then we combined our efforts into a proof of concept.
We also worked with other teams in the spirit of iGEM collaboration to test our
projects in new environments.
-
Synthetic mammalian promoters designed with repeating protein binding sequences demonstrated
significant increase in reporter activity when induced with estrogen or progesterone in hormone-sensitive cell lines.
-
Observed change in microRNA activity in an endometrial cell line under different conditions
and characterized microRNA target site sensitivity.
-
Serine recombinase TP901 successfully activates flipped EYFP when the upstream promoter is induced
and L7Ae/k-turn, RNA-based gene repressing system, reduces basal expression of the recombinase.
-
Read about a summary of our results and how our sensors interact logically after transfection of
4 to 5-unit genetic circuits into model cell cultures
-
Read about how we worked with other iGEM teams throughout our project